← back to search

Romain Basmaci

National Cheng Kung University Hospital · FR
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Orthopedic Infections and Treatments, COVID-19 Clinical Research Studies, Respiratory viral infections research, and SARS-CoV-2 and COVID-19 Research.
h-index
38
citations
11,016
works
153
NIH funding
primary concept
Medicine
email

Recent publications

Point-of-care decision rule for antibiotic prescriptions in young children with fever without source: an open cluster randomised trial.
2026cited by 0position: contributordoi
Infection-related mortality in children in two European countries, 2015–2023: An interrupted time-series analysis
Journal of Infection 2026cited by 0position: contributordoi
Immunity to <i>Streptococcus pyogenes</i> and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions
JAMA Network Open 2025cited by 7position: middledoi
Clinical features, treatment and outcomes of acute ethmoiditis: A case series of 20 hospitalized children
Archives de Pédiatrie 2025cited by 0position: contributordoi
Surge of Pediatric Respiratory Tract Infections after the COVID-19 Pandemic and the Concept of “Immune Debt”
The Journal of Pediatrics 2024cited by 34position: middledoi
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases
The Pediatric Infectious Disease Journal 2024cited by 11position: middledoi
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases.
2024cited by 11position: contributordoi
Antibiotic therapy for osteoarticular infections in 2023: Proposals from the Pediatric Infectious Pathology Group (GPIP)
Infectious Diseases Now 2023cited by 26position: middledoi
Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases
2023cited by 0position: contributordoi
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
The Lancet Regional Health - Europe 2022cited by 68position: middledoi
Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study
PLoS Medicine 2022cited by 39position: middledoi
Respective roles of non-pharmaceutical interventions in bronchiolitis outbreaks: an interrupted time-series analysis based on a multinational surveillance system
European Respiratory Journal 2022cited by 29position: middledoi
Availability and use of rapid diagnostic tests for the management of acute childhood infections in Europe: A cross-sectional survey of paediatricians
PLoS ONE 2022cited by 26position: middledoi
Patterns of presentations of children to emergency departments across Europe and the impact of the COVID-19 pandemic: retrospective observational multinational study
2022cited by 0position: contributordoi
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children
JAMA 2021cited by 366position: middledoi
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Clinical Infectious Diseases 2021cited by 40position: middledoi
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
BMJ 2020cited by 1,137position: middledoi
Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections—a Time Series Analysis
Clinical Infectious Diseases 2020cited by 321position: middledoi
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study
The Lancet Child & Adolescent Health 2020cited by 218position: middledoi
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
Clinical Microbiology and Infection 2020cited by 76position: middledoi
Type I Interferon in Children with Viral or Bacterial Infections
Clinical Chemistry 2020cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

François Angoulvant · Hôpital de l'enfance3 papers (2020–2026) · 3 papers (2025–2026)Jacques Fourgeaud · Institut Pasteur1 papers (2020–2020)Julie Toubiana · National Patient Safety Foundation1 papers (2020–2020) · 1 papers (2020–2020)Fanny Bajolle · Hôpital Necker-Enfants Malades1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2023–2023)Sandra Biscardi · Institut Mondor de Recherche Biomédicale1 papers (2020–2020)Robert Cohen · Enzo Life Sciences (United States)1 papers (2023–2023)Yves Gillet · Centre International de Recherche en Infectiologie1 papers (2023–2023) · 1 papers (2020–2020)Alain Gervaix · University of Geneva1 papers (2026–2026)Jean‐Laurent Casanova · Tehran University of Medical Sciences1 papers (2020–2020)David Dawei Yang · Assistance Publique – Hôpitaux de Paris1 papers (2020–2020) · 1 papers (2020–2020)David Skurnik · Université Claude Bernard Lyon 11 papers (2020–2020) · 1 papers (2023–2023)Luc Panetta · Université Claude Bernard Lyon 11 papers (2023–2023) · 1 papers (2023–2023)